WHO admits Kazakh coronavirus vaccine for clinical trials



NUR-SULTAN, Kazakhstan – The World Health Organization has included the Kazakh inactivated vaccine against COVID-19 in the list of approved for clinical trials, the official website of the Kazakh operational headquarters for the fight against coronavirus said on August 31.

The list includes 33 vaccines from 19 countries: Great Britain, China, Russia, USA, Germany, Japan, India, South Korea, Belgium, Sweden, Singapore, Italy, Australia, Taiwan, Cuba, France, Austria, Canada.

Earlier, WHO registered the development of Kazakh scientists and included it in the list of candidate vaccines against COVID-19, which are allowed preclinical studies.

Earlier, Kazakhstan’s Education and Science Minister Askhat Aimagambetov said preclinical trials of the QazCovid-in vaccine had already been completed and gave good results.

The inactivated vaccine was developed by employees of the Kazakhstan Scientific Research Institute for Biological Safety Problems. It was created on the basis of a virus strain isolated from patients in Kazakhstan.



Source link